Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2018 Filed May 24, 2018 20:31 UTC |
Drake Scott WilliamDirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032982 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,026 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:20 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GiftCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030894 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,896 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:28 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 4,000 | $23.05 | $92,200.00 |
DisclosureSEC source: 0001209191-18-030916 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,920 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.93 to $23.39 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 08, 2018 Filed May 9, 2018 13:00 UTC |
Krell Elizabeth DDirector
|
SaleCommon Stock | 10,000 | $22.82 | $228,200.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.63 to $22.97 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 07, 2018 Filed May 9, 2018 13:00 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 23, 2013 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 07, 2018 Filed May 9, 2018 13:00 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.30 | $93,000.00 |
DisclosureSEC source: 0001209191-18-028735 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 20:34 UTC |
Krell Elizabeth DDirector
|
SaleCommon Stock | 10,000 | $20.00 | $200,000.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $19.88 to $20.15 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:34 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:34 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionCommon Stock | 10,000 | $14.17 | $141,700.00 |
DisclosureSEC source: 0001209191-18-019568 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 16:49 UTC |
Lanning Mark RDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001209191-18-015732 · doc4.xml · derivative · entry 3 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on May 28, 2008 and is exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 16:49 UTC |
Lanning Mark RDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.10 | $101,000.00 |
DisclosureSEC source: 0001209191-18-015732 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 1, 2018 21:03 UTC |
GROVES REGINA EDirector
|
PurchaseCommon Stock | 1,000 | $17.43 | $17,430.00 |
DisclosureSEC source: 0001209191-18-014940 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,469 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:38 UTC |
Drake Scott WilliamDirector
|
PurchaseCommon Stock | 11,000 | $17.64 | $194,040.00 |
DisclosureSEC source: 0001209191-18-015689 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,805 F1 · price: This transaction was executed in multiple trades at prices ranging from $17.36 to $17.91 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:16 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Tax withholdingCommon Stock | 14,803 | $17.71 | $262,161.13 |
DisclosureSEC source: 0001209191-18-016413 · doc4.xml · nonDerivative · entry 2 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,920 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:16 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GrantCommon Stock | 25,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016413 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,723 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:11 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Tax withholdingCommon Stock | 19,740 | $17.71 | $349,595.40 |
DisclosureSEC source: 0001209191-18-016400 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,221 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:11 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 95,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016400 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731,961 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:29 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 14,969 | $17.71 | $265,100.99 |
DisclosureSEC source: 0001209191-18-016462 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,757 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:29 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 35,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016462 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,726 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:24 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 19,677 | $17.71 | $348,479.67 |
DisclosureSEC source: 0001209191-18-016449 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,739 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:24 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 35,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016449 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,416 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:20 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 21,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016428 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,174 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 21:11 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 4,000 | $17.03 | $68,120.00 |
DisclosureSEC source: 0001209191-18-010820 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,997 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.62 to $17.40 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 12:58 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Tax withholdingCommon Stock | 33,167 | $17.55 | $582,080.85 |
DisclosureSEC source: 0001209191-18-005491 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,676 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 13:08 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 3,791 | $17.55 | $66,532.05 |
DisclosureSEC source: 0001209191-18-005495 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,730 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 13:03 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 3,275 | $17.55 | $57,476.25 |
DisclosureSEC source: 0001209191-18-005493 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,420 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 08:02 UTC |
Collar Mark ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.31 | $0.00 |
DisclosureSEC source: 0001209191-18-004677 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on February 6, 2008 and is exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 08:02 UTC |
Collar Mark ADirector
|
Exercise / conversionCommon Stock | 25,000 | $13.31 | $332,750.00 |
DisclosureSEC source: 0001209191-18-004677 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 13:37 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Tax withholdingCommon Stock | 3,182 | $17.99 | $57,244.18 |
DisclosureSEC source: 0001209191-18-002832 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,997 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| December 29, 2017 Filed Jan 8, 2018 21:06 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 547 | $15.50 | $8,478.50 |
DisclosureSEC source: 0001209191-18-002707 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,843 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017. F2 · price: Closing price on December 29, 2017 was $18.24. Read SEC document |
| December 29, 2017 Filed Jan 8, 2018 21:11 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 571 | $15.50 | $8,850.50 |
DisclosureSEC source: 0001209191-18-002712 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,521 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017. F2 · price: Closing price on December 29, 2017 was $18.24. Read SEC document |
| December 29, 2017 Filed Jan 8, 2018 21:09 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 328 | $15.50 | $5,084.00 |
DisclosureSEC source: 0001209191-18-002709 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,695 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017. F2 · price: Closing price on December 29, 2017 was $18.24. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 21:37 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $11.65 | $0.00 |
DisclosureSEC source: 0001209191-17-063221 · doc4.xml · derivative · entry 3 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on December 5, 2007 and is exercisable as to 25% of the shares upon the one year anniversary of the date of the grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 21:37 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 2,000 | $18.41 | $36,820.00 |
DisclosureSEC source: 0001209191-17-063221 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,950 F1 · price: This transaction was executed in multiple trades at prices ranging from $18.40 to $18.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 21:37 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionCommon Stock | 2,000 | $11.65 | $23,300.00 |
DisclosureSEC source: 0001209191-17-063221 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2017 Filed Dec 4, 2017 21:16 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-063525 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,296 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 20:01 UTC |
JOHNSON B KRISTINEDirector
|
PurchaseCommon Stock | 1,500 | $18.36 | $27,540.00 |
DisclosureSEC source: 0001209191-17-059936 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,969 Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 16:19 UTC |
Collar Mark ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.31 | $0.00 |
DisclosureSEC source: 0001209191-17-053155 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on February 6, 2008 and is exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 16:19 UTC |
Collar Mark ADirector
|
Exercise / conversionCommon Stock | 25,000 | $13.31 | $332,750.00 |
DisclosureSEC source: 0001209191-17-053155 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 13:08 UTC |
Krell Elizabeth DDirector
|
SaleCommon Stock | 10,000 | $22.40 | $224,000.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.35 to $22.52 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 13:08 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 15, 2012 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 13:08 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionCommon Stock | 10,000 | $8.04 | $80,400.00 |
DisclosureSEC source: 0001209191-17-049892 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 21:12 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047434 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,179 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 21:02 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046206 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. Amended and Restated 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:15 UTC |
LUX ANDREW LSVP, Ops & Quality
|
GrantCommon Stock | 960 | $16.32 | $15,667.20 |
DisclosureSEC source: 0001209191-17-043289 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,549 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2017. F2 · price: Closing price on June 30, 2017 was $24.25. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:11 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 612 | $16.32 | $9,987.84 |
DisclosureSEC source: 0001209191-17-043271 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670,696 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2017. F2 · price: Closing price on June 30, 2017 was $24.25. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:22 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 529 | $16.32 | $8,633.28 |
DisclosureSEC source: 0001209191-17-043330 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,950 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2017. F2 · price: Closing price on June 30, 2017 was $24.25. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 888 | $16.32 | $14,492.16 |
DisclosureSEC source: 0001209191-17-043314 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,367 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2017. F2 · price: Closing price on June 30, 2017 was $24.25. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · derivative · entry 12 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 21,100 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · derivative · entry 11 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,100 shares Expires 2022-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on October 25, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.